Primary Androgen Deprivation Tx Ups Diabetes Risk by 60 Percent

This article originally appeared here.
Share this content:
Primary Androgen Deprivation Tx Ups Diabetes Risk by 60 Percent
Primary Androgen Deprivation Tx Ups Diabetes Risk by 60 Percent

THURSDAY, May 28, 2015 (HealthDay News) -- Primary androgen deprivation therapy increases diabetes risk, particularly in men under 70 years of age, according to research published in the June issue of The Journal of Urology.

Huei-Ting Tsai, Ph.D., from the Georgetown University Medical Center in Washington, D.C., and colleagues analyzed retrospective data from 12,191 men diagnosed with incident localized prostate cancer from 1995 to 2008 (age 35 to 100 years). The men were without diabetes at diagnosis and did not receive prostatectomy or radiation. Primary androgen deprivation therapy was characterized as occurring within one year of diagnosis.

The researchers found that over a median 4.8 years of follow up, 9.9 percent of patients developed diabetes. The respective incidence rates were 2.5 and 1.6 events per 100 person-years in the primary androgen deprivation therapy and nonprimary androgen deprivation therapy groups. There was a 1.61-fold increase in diabetes risk with primary androgen deprivation therapy. The number needed to harm was 29. In men ≤70 years, the association was stronger, compared to older men (HR 2.25 versus 1.40; P = 0.008).

"Primary androgen deprivation therapy may increase diabetes risk by 60 percent and should be used with caution when managing localized prostate cancer," the authors write. "Because of the consistent association between androgen deprivation therapy and greater diabetes risk across disease states, we recommend routine screening and lifestyle interventions to reduce the risk of diabetes in men receiving androgen deprivation therapy."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Surveillance Frequency Doesn't Cut Mortality in Colorectal Cancer

Surveillance Frequency Doesn't Cut Mortality in Colorectal Cancer

And, intensity of imaging surveillance not linked to time to detection of colorectal cancer recurrence

Procalcitonin Assay Doesn't Cut Antibiotic Use in Lower RTI

Procalcitonin Assay Doesn't Cut Antibiotic Use in Lower ...

Provision of assay doesn't result in less antibiotic use for suspected lower respiratory tract infection

Preventing Child Maltreatment Not Yet Feasible in Primary Care

Preventing Child Maltreatment Not Yet Feasible in Primary ...

USPSTF says evidence inadequate for primary care interventions to prevent child maltreatment

is free, fast, and customized just for you!

Already a member?

Sign In Now »